Literature DB >> 23245997

[Prevention of post intravitreal injection endophthalmitis: is antibioprophylaxis indicated?].

I Cochereau1, J-F Korobelnik, B Bodaghi.   

Abstract

Endophthalmitis remains the main complication of intravitreal injections, especially because their repetition multiplicates the risks. Surgical antisepsis is required for the prevention of endophthalmitis, but the benefit/risk ratio of topical antibioprophylaxis has never been demonstrated. In contrast, the selection of resistant bacteria appears to be exponential with the wider use of topical antibioprophylaxis. It seems that more and more operators stop using anibioprophylaxis, provided that the antisepsis is surgical and that the injection is performed in accordance with the rules of good practice.
Copyright © 2012. Published by Elsevier Masson SAS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23245997     DOI: 10.1016/j.jfo.2012.10.001

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  2 in total

1.  Reply to Dr Grzybowski.

Authors:  K G Falavarjani; Q D Nguyen
Journal:  Eye (Lond)       Date:  2014-01-10       Impact factor: 3.775

Review 2.  Antibioprophylaxis in Prevention of Endophthalmitis in Intravitreal Injection: A Systematic Review and Meta-Analysis.

Authors:  Cédric Benoist d'Azy; Bruno Pereira; Geraldine Naughton; Frédéric Chiambaretta; Frédéric Dutheil
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.